Latest news
'Celltrion Partner' Kaigene Licenses Autoimmune Drug to Japan's Taisho - Seoul Economic DailySeoul Economic Daily · Fri, 31 Jul 2026 05:50:35 GMTG2G Bio Partners with Celltrion to Co-Develop Ultra-High Concentration Antibody SC Platform - finance.biggo.comfinance.biggo.com · Thu, 30 Jul 2026 09:35:00 GMT